• Olink and the COVID-19 pandemic

    Open for business while taking all necessary precautions!

    As a provider of protein biomarker solutions for scientists seeking to re-shape future healthcare, Olink is taking the COVID-19 pandemic situation extremely seriously, while maintaining its commitment to support crucial studies that will help to develop future medicine well beyond the current crisis. We understand that this is a difficult and uncertain time and want to reassure everyone that we are here to support you and remain very much open for business –  we are able to receive and analyze your samples at our Analysis Service labs in Uppsala and Boston, and provide you with the results from your studies.

    At the same time, we are taking all possible precautions to maintain our activities in a safe and responsible manner, and to rigorously follow the evolving advice and instructions from the appropriate local and national authorities. This includes minimizing access to our facilities to essential on-site lab and production staff and exploiting digital alternatives for meetings.

    As a company that takes transparent dialog with our customers extremely seriously, we felt it important to share this information with you, and we will of course update you if there are any significant changes to the current situation regarding Olink’s ability to continue analyzing your samples.

    If you have any questions or concerns, please do not hesitate to contact us.